News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LANGE LOUIS G
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/15/2020 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Unknown transaction of 265,799 shares
@ $60, valued at
$15.9M
Unknown transaction of 13,678 shares
@ $60, valued at
$820.7k
Unknown transaction of 32,343 shares
@ $60, valued at
$1.9M
Unknown transaction of 3,555 shares
@ $60, valued at
$213.3k
Disposed/sold 18,000 options to buy
@ $15.03, valued at
$270.5k
Disposed/sold 9,000 options to buy
@ $0
Disposed/sold 10,000 options to buy
@ $38.65, valued at
$386.5k
Disposed/sold 16,200 options to buy
@ $24.74, valued at
$400.8k
|
|
| 12/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2019 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 9,755 shares
@ $32.149, valued at
$313.6k
Sold 245 shares
@ $32.6628, valued at
$8k
Sold 1,000 shares
@ $32.182, valued at
$32.2k
|
|
| 06/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2019 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 19,700 shares
@ $35.991, valued at
$709k
Sold 300 shares
@ $36.6406, valued at
$11k
Sold 1,000 shares
@ $36.0037, valued at
$36k
Sold 558 shares
@ $35.9403, valued at
$20.1k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2018 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $18.6717, valued at
$373.4k
Sold 1,000 shares
@ $18.701, valued at
$18.7k
Sold 1,000 shares
@ $18.713, valued at
$18.7k
Sold 10,000 shares
@ $18.4951, valued at
$185k
|
|
| 11/16/2018 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $22.49, valued at
$449.8k
Sold 4,000 shares
@ $22.49, valued at
$90k
|
|
| 09/26/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2018 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 18,860 shares
@ $40.3635, valued at
$761.3k
Sold 1,140 shares
@ $41.3053, valued at
$47.1k
Sold 1,000 shares
@ $40.783, valued at
$40.8k
Sold 900 shares
@ $40.7916, valued at
$36.7k
Sold 100 shares
@ $41.46, valued at
$4.1k
Sold 900 shares
@ $40.7356, valued at
$36.7k
Sold 100 shares
@ $41.47, valued at
$4.1k
Sold 9,790 shares
@ $40.8618, valued at
$400k
Sold 210 shares
@ $41.27, valued at
$8.7k
|
|
| 06/08/2018 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $38.65, valued at
$386.5k
|
|
| 03/28/2018 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 11,568 shares
@ $29, valued at
$335.5k
Sold 6,700 shares
@ $29.57, valued at
$198.1k
Sold 1,732 shares
@ $29.95, valued at
$51.9k
Sold 500 shares
@ $28.284, valued at
$14.1k
Sold 500 shares
@ $29.464, valued at
$14.7k
Sold 600 shares
@ $28.38, valued at
$17k
Sold 400 shares
@ $29.5725, valued at
$11.8k
Sold 517 shares
@ $28.3206, valued at
$14.6k
Sold 483 shares
@ $29.5695, valued at
$14.3k
Sold 18,400 shares
@ $28.3514, valued at
$521.7k
Sold 6,600 shares
@ $29.2655, valued at
$193.2k
|
|
| 12/26/2017 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $30.8773, valued at
$463.2k
Sold 1,000 shares
@ $30.9019, valued at
$30.9k
Sold 1,000 shares
@ $30.8581, valued at
$30.9k
Sold 1,000 shares
@ $30.8727, valued at
$30.9k
|
|
| 10/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2017 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 4,244 shares
@ $28.3106, valued at
$120.2k
Sold 756 shares
@ $29.3188, valued at
$22.2k
Sold 1,700 shares
@ $28.1235, valued at
$47.8k
Sold 300 shares
@ $29.26, valued at
$8.8k
Sold 1,800 shares
@ $28.1419, valued at
$50.7k
Sold 200 shares
@ $29.24, valued at
$5.8k
Sold 1,800 shares
@ $28.1377, valued at
$50.6k
Sold 200 shares
@ $29.245, valued at
$5.8k
|
|
| 09/26/2017 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc.|
Txns:
| Sold 7,406 shares
@ $27.8482, valued at
$206.2k
Sold 7,594 shares
@ $28.7632, valued at
$218.4k
Sold 600 shares
@ $27.9933, valued at
$16.8k
Sold 400 shares
@ $28.8874, valued at
$11.6k
Sold 636 shares
@ $28.0607, valued at
$17.8k
Sold 364 shares
@ $28.8478, valued at
$10.5k
Sold 641 shares
@ $28.0664, valued at
$18k
Sold 359 shares
@ $28.8757, valued at
$10.4k
|
|
| 06/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/25/2016 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc. |
| 07/25/2016 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on Audentes Therapeutics, Inc. |
| 06/30/2015 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $2.97, valued at
$26.7k
|
|
| 01/08/2015 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 9,000 options to buy
@ $10, valued at
$90k
|
|
| 01/15/2014 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 12,972 rights
@ $5, valued at
$64.9k
|
|
| 01/08/2014 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Granted 21,260 options to buy
@ $5, valued at
$106.3k
|
|
| 12/27/2013 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Disposed/sold 122 options to buy
@ $39.75, valued at
$4.8k
Granted 122 options to buy
@ $5, valued at
$610
Disposed/sold 455 options to buy
@ $39.75, valued at
$18.1k
Granted 455 options to buy
@ $5, valued at
$2.3k
Disposed/sold 3,144 options to buy
@ $15.9, valued at
$50k
Granted 3,144 options to buy
@ $5, valued at
$15.7k
|
|
| 11/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2013 |
3
| LANGE LOUIS G (Director) has filed a Form 3 on Esperion Therapeutics, Inc. |
| 06/07/2012 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on MAXYGEN INC|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 06/01/2011 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on MAXYGEN INC|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 05/27/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/24/2009 |
4
| LANGE LOUIS G (Director) has filed a Form 4 on MAXYGEN INC |
| 06/05/2009 |
4
| LANGE LOUIS G (Former EVP Cardio Therapeutics) has filed a Form 4 on GILEAD SCIENCES INC |
| 05/08/2009 |
4
| LANGE LOUIS G (EVP Cardiovascular Therapeutic) has filed a Form 4 on GILEAD SCIENCES INC |
|
|
|